Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
- PMID: 12851636
- DOI: 10.1038/sj.mp.4001308
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Abstract
Anatomical and molecular abnormalities of excitatory neurons in the dorsolateral prefrontal cortex (DLPFC) are found in schizophrenia. We hypothesized that brain-derived neurotrophic factor (BDNF), a protein capable of increasing pyramidal neuron spine density and augmenting synaptic efficacy of glutamate, may be abnormally expressed in the DLPFC of patients with schizophrenia. Using an RNase protection assay and Western blotting, we detected a significant reduction in BDNF mRNA (mean=23%) and protein (mean=40%) in the DLPFC of patients with schizophrenia compared to normal individuals. At the cellular level, BDNF mRNA was expressed at varying intensities in pyramidal neurons throughout layers II, III, V, and VI of DLPFC. In patients with schizophrenia; neuronal BDNF expression was decreased in layers III, V and VI. Our study demonstrates a reduction in BDNF production and availability in the DLPFC of schizophrenics, and suggests that intrinsic cortical neurons, afferent neurons, and _target neurons may receive less trophic support in this disorder.
Similar articles
-
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.Mol Psychiatry. 2005 Jul;10(7):637-50. doi: 10.1038/sj.mp.4001678. Mol Psychiatry. 2005. PMID: 15940304
-
Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortex.Eur J Neurosci. 2009 Apr;29(7):1311-22. doi: 10.1111/j.1460-9568.2009.06669.x. Epub 2009 Mar 23. Eur J Neurosci. 2009. PMID: 19519623
-
Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor.Biol Psychiatry. 2005 Apr 15;57(8):932-4. doi: 10.1016/j.biopsych.2005.01.010. Biol Psychiatry. 2005. PMID: 15820715
-
Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.Int Rev Neurobiol. 2007;78:377-95. doi: 10.1016/S0074-7742(06)78012-6. Int Rev Neurobiol. 2007. PMID: 17349867 Review.
-
Brain-derived neurotrophic factor: findings in schizophrenia.Curr Opin Psychiatry. 2011 Mar;24(2):122-7. doi: 10.1097/YCO.0b013e3283436eb7. Curr Opin Psychiatry. 2011. PMID: 21248641 Review.
Cited by
-
Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.J Neuroimmune Pharmacol. 2012 Sep;7(3):656-64. doi: 10.1007/s11481-012-9382-z. Epub 2012 Jun 23. J Neuroimmune Pharmacol. 2012. PMID: 22730040 Free PMC article. Clinical Trial.
-
Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.Psychopharmacology (Berl). 2012 Jul;222(2):277-84. doi: 10.1007/s00213-012-2643-y. Epub 2012 Jan 26. Psychopharmacology (Berl). 2012. PMID: 22274000
-
A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex.Int J Neuropsychopharmacol. 2013 Mar;16(2):477-83. doi: 10.1017/S1461145712000685. Epub 2012 Jul 25. Int J Neuropsychopharmacol. 2013. PMID: 22827965 Free PMC article.
-
Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.Am J Psychiatry. 2017 Feb 1;174(2):163-171. doi: 10.1176/appi.ajp.2016.16020204. Epub 2016 Aug 13. Am J Psychiatry. 2017. PMID: 27523502 Free PMC article.
-
Sex Differences in Psychosis: Focus on Animal Models.Curr Top Behav Neurosci. 2023;62:133-163. doi: 10.1007/7854_2022_305. Curr Top Behav Neurosci. 2023. PMID: 35243605 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical